Last updated on January 2019

Korean Post-marketing Surveillance for Xeljanz


Brief description of study

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Clinical Study Identifier: NCT02984020

Contact Investigators or Research Sites near you

Start Over

Dankook University Hospotal

Cheonan, Korea, Republic of
  Connect »

Konkuk University Chungju Hospital

Chungju-si, Korea, Republic of
  Connect »

Division of Rheumatology

Seongnam-si, Korea, Republic of
  Connect »

CHA Bundang Medical Center

Seongnam-si, Korea, Republic of
  Connect »

Chungbuk National University Hospital

Chungcheongbuk-do, Korea, Republic of
  Connect »

Inje University IlsanPaik Hospital

Goyang-si, Gyeonggi-do, Korea, Republic of
  Connect »

Division of Rheumatology

Incheon, Korea, Republic of
  Connect »

Division of Rheumatology

Metropolitan City, Daejeon, Korea, Republic of
  Connect »

Eulji Medical Center

Seoul, Korea, Republic of
  Connect »

Division of Rheumatology

Seoul, Korea, Republic of
  Connect »

Dong-A University Hospital

Pusan, Korea, Republic of
  Connect »

Jeju National University Hospital

Jeju Special Self-Goverming Province, Korea, Republic of
  Connect »

Korea University Ansan Hospital

Ansan, Gyeonggi-do, Korea, Republic of
  Connect »

Gachon University Gil Hospital

Incheon, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.